Recent reports in glioblastoma have demonstrated that asymmetric enrichment of EGFR and p75NTR in a daughter cell during cell division conferred enhanced resistance to the standard-of-care therapies, such as radiation and temozolomide [52]. This evidence concerns the gene NGFR and glioblastoma.